美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
70771-1764-6	70771-1764	HUMAN PRESCRIPTION DRUG	Lubiprostone	Lubiprostone	CAPSULE	ORAL	20230323	N/A	ANDA	ANDA214131	Zydus Lifesciences Limited	LUBIPROSTONE	24 ug/1	60 CAPSULE in 1 BOTTLE (70771-1764-6)
70771-1764-1	70771-1764	HUMAN PRESCRIPTION DRUG	Lubiprostone	Lubiprostone	CAPSULE	ORAL	20230323	N/A	ANDA	ANDA214131	Zydus Lifesciences Limited	LUBIPROSTONE	24 ug/1	100 CAPSULE in 1 BOTTLE (70771-1764-1)
70771-1763-6	70771-1763	HUMAN PRESCRIPTION DRUG	Lubiprostone	Lubiprostone	CAPSULE	ORAL	20230323	N/A	ANDA	ANDA214131	Zydus Lifesciences Limited	LUBIPROSTONE	8 ug/1	60 CAPSULE in 1 BOTTLE (70771-1763-6)
70771-1763-1	70771-1763	HUMAN PRESCRIPTION DRUG	Lubiprostone	Lubiprostone	CAPSULE	ORAL	20230323	N/A	ANDA	ANDA214131	Zydus Lifesciences Limited	LUBIPROSTONE	8 ug/1	100 CAPSULE in 1 BOTTLE (70771-1763-1)
70710-1641-1	70710-1641	HUMAN PRESCRIPTION DRUG	Lubiprostone	Lubiprostone	CAPSULE	ORAL	20230323	N/A	ANDA	ANDA214131	Zydus Pharmaceuticals USA Inc.	LUBIPROSTONE	8 ug/1	100 CAPSULE in 1 BOTTLE (70710-1641-1)
70710-1641-6	70710-1641	HUMAN PRESCRIPTION DRUG	Lubiprostone	Lubiprostone	CAPSULE	ORAL	20230323	N/A	ANDA	ANDA214131	Zydus Pharmaceuticals USA Inc.	LUBIPROSTONE	8 ug/1	60 CAPSULE in 1 BOTTLE (70710-1641-6)
70710-1642-1	70710-1642	HUMAN PRESCRIPTION DRUG	Lubiprostone	Lubiprostone	CAPSULE	ORAL	20230323	N/A	ANDA	ANDA214131	Zydus Pharmaceuticals USA Inc.	LUBIPROSTONE	24 ug/1	100 CAPSULE in 1 BOTTLE (70710-1642-1)
70710-1642-6	70710-1642	HUMAN PRESCRIPTION DRUG	Lubiprostone	Lubiprostone	CAPSULE	ORAL	20230323	N/A	ANDA	ANDA214131	Zydus Pharmaceuticals USA Inc.	LUBIPROSTONE	24 ug/1	60 CAPSULE in 1 BOTTLE (70710-1642-6)